Last Updated: 06/06/2026

Locate Bio

Nottingham

Founded 2001

Controlled-release orthobiologics for spinal fusion and bone repair

Locate Bio is a clinical-stage biotechnology company developing a portfolio of orthobiologic products for musculoskeletal surgery.

Its proprietary Programmed Drug Release platform encapsulates recombinant proteins within biodegradable polymer scaffolds to enable controlled, extended-release delivery.

Lead product LDGraft is an rhBMP-2 bone graft substitute in clinical trial for lumbar interbody fusion, having received FDA Breakthrough Device Designation.

The pipeline also includes synthetic bone graft substitutes and antibiotic-eluting scaffolds for osteomyelitis.

Biotech Biomaterials Drug Discovery

Musculoskeletal Bioabsorbable Polymers Growth Factors Antimicrobial Resistance

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Claim page